Company Overview and News

Big challenges offer great opportunities: SAIL chief

New Delhi : Big challenges offer great opportunities, said Steel Authority of India Ltd. (SAIL), Chairman P K Singh. He also spoke about the new mantra while interacting with the Company’s entire marketing team and employees of local SAIL units at Kolkata.

No fresh investment in SAIL, RINL till project completion

For the coming three years,  SAIL & RINL must complete their incomplete projects and start getting return on their investment for  fresh fund from Centre.

SAIL, ArcelorMittal steel unit’s site to be sealed in 3 months

New Delhi : The Rs 5,000-crore autograde steel plant in joint venture between SAIL and ArcelorMittal would be set up close to an automobile hub and final decision on the site is likely in three months, a top official on Thursday said.     “It (SAIL, ArcelorMittal JV) is in the final stage now. Absolutely in the final stage,” Steel Secretary Aruna Sharma told PTI in an interview. Steel Authority of India (SAIL) and ArcelorMittal had in May, 2015 entered into a memorandum of understanding (MoU) to explore the possibility of setting up an autograde steel manufacturing facility under a joint venture in India.

After damning report, government tries to revive the steel giant SAIL and RINL

The government has set up a committee to suggest measures to fast-track the ramping up of modernisation of the steel sector public sector firms SAIL and RINL. A high-level meeting called by the Union Minister for Steel, Chaudhary Birender Singh, with senior officials in New Delhi took the decision on Wednesday. M.K. Raghavan, Kozhikode MP, had taken up the issue with the Centre.

Coal price hike: SAIL didn’t turn up for talks with CIL

New Delhi : State-owned Coal India raised the prices of coking coal in January without any discussion with its key customer SAIL as the steel major did not turn up for deliberations despite repeated pleas by the miner, a top official said on Monday.

CARE lowers rating of SAIL’s long-term debt

2016-03-17 financialexpress
Steel Authority of India (SAIL) was downgraded by CARE Ratings on Wednesday, with the rating lowered by a notch to AA+ for long-term debt worth more than Rs 15,000 crore, reports fe Bureau in Mumbai. The agency cited a subdued financial performance in the first nine months of fiscal 2015-16 that led to moderation in key credit metrics.

CARE downgrades rating on SAIL

2016-03-17 livemint
Mumbai: Ratings agency CARE Ratings on Wednesday downgraded the credit rating for Steel Authority of India Ltd (SAIL) from AAA to AA+ due to subdued financial performance.

NMDC, SAIL shares rally on firm iron ore prices, China’s metal trade data

2016-03-09 financialexpress
Shares of miners NMDC and Steel Authority of India surged upto 11 per cent on Tuesday on robust metals trade data from China and soaring iron ore prices.

Rail Budget a major boost for logistics companies, steel manufacturers

2016-02-25 thehindubusinessline
New rail lines, wagon addition, dedicated freight corridors to spur growth

SAIL to invest over Rs 10,200 cr on mines

2016-02-24 moneycontrol
To a query on demand and supply of steel, Sai said with a crude steel production capacity of about 101 MT (million tonnes) in 2013-14, India produced about 87.67 MT of finished steel with an apparent consumption of about 74.09 MT...

Coal Ministry warns SAIL of cancelling mine allotment for delays

2016-02-24 moneycontrol
The Ministry has also warned the PSU of terminating the allotment agreement if the steel firm fails to give an explanation for the delay in submission of completion notice...

Steel industry seeks special package from Centre, banks

2016-02-16 thehindubusinessline
Calls for moratorium on payment of interest and principal amount

Steel industry seeks special financial package 

2016-02-16 thehindubusinessline
The Indian Steel Association has sought a special financial package from the governmen

Indian steelmakers raise prices, but surge in value not likely

2016-02-12 in.reuters
MUMBAI/NEW DELHI Some steelmakers have raised their prices after a recent government measure to rein in cheap imports, but a surge in value is unlikely as the country's production capacity is rising faster than its domestic demand growth.

Domestic steel companies hike prices by up to 4%

2016-02-11 business-standard
Prices may be hiked further but only marginally, say industry leaders

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

23h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...